Download App

Log in to access Online Inquiry
Company Overview More
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company’s SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
CEO: Cohen, Raymond W.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > AXNX Axonics > Detailed Quotes

AXNX Axonics

49.310+0.690+1.42%
Close 05/19 20:00 ET
High
50.030
Open
47.900
Turnover
26.09M
Low
47.705
Pre Close
48.620
Volume
532.18K
Market Cap
2.32B
P/E(TTM)
Loss
52wk High
79.810
Shares
47.07M
P/E(Static)
Loss
52wk Low
38.410
Float Cap
2.25B
Bid/Ask %
-100.00%
Historical High
79.810
Shs Float
45.66M
Volume Ratio
0.93
Historical Low
11.950
Dividend TTM
--
Div Yield TTM
70
P/B
5.01
Dividend LFY
--
Div Yield LFY
141.96%
Turnover Ratio
1.17%
Amplitude
4.78%
Avg Price
49.015
Lot Size
1
Float Cap
2.25B
Bid/Ask %
-100.00%
Historical High
79.810
Shs Float
45.66M
Volume Ratio
0.93
Historical Low
11.950
Dividend TTM
--
P/B
5.01
Dividend LFY
--
Turnover Ratio
1.17%
Amplitude
4.78%
Avg Price
49.015
Lot Size
1
Price Forecast

No Data

News

Comment